• Home
  • /
  • Abstract
  • /
  • Abstract Presentation
  • Abstract Presentation

Evaluating the Safety, Tolerability, and Pharmacokinetics of QRL-101 in Two Phase 1 Studies: QRL-101-01 in Healthy Adults and QRL-101-02 in Adults With ALS

Clinical Listing
Submit Abstract Register Online